Comparative study of the efficacy of intravitreal ranibizumab versus its combination with intravitreal dexamethasone in the treatment of diabetic macular edema
Diabetic macular edema imposes a substantial cause of central vision loss worldwide. Anti- vascular endothelial growth factor therapy, such as ranibizumab, has become the standard of care for diabetic macular edema. In this study, we investigated the effect of using combined therapy of ranibizumab and dexamethasone...